IP Library Granted Patent US 9,920,358
Granted Patent B2
US 9,920,358 · App. 14/385,674 · Granted Mar 20, 2018

Helicase suppression of non-template amplification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,920,358
App. No.
14/385,674
Granted
Mar 20, 2018
Kind
B2
Abstract

Provided herein is a method for reducing amplification of non-template molecules in a nucleic acid sample. In certain embodiments, the method involves adding a helicase to a reaction mixture for non-helicase-dependent amplification of target nucleic acid.

Claims (34)

1. A reaction mixture comprising:

a) a nucleic acid sample comprising a template;

b) nucleotides;

c) four or more primers;

d) a polymerase; and

e) a non-thermostable helicase;

wherein the reaction mixture does not contain a single-stranded DNA binding protein (SSBP) and wherein the reaction mixture is capable of amplifying the template when placed under isothermal or polymerase chain reaction conditions.

2. The reaction mixture of claim 1 , wherein the helicase is a PcrA/UvrD/Rep helicase.

3. The reaction mixture of claim 1 , wherein the polymerase is a strand-displacing polymerase.

4. The reaction mixture of claim 3 , wherein the polymerase is selected from the group consisting of a Bst polymerase, a polD polymerase, a 9° N polymerase and phi29 polymerase.

5. The reaction mixture of claim 1 , wherein the polymerase is a thermostable polymerase.

6. The reaction mixture of claim 1 , wherein the template is RNA and the polymerase is a reverse transcriptase.

7. The reaction mixture of claim 1 , wherein the template is genomic DNA.

8. A method for reducing amplification of non-template molecules from a nucleic acid sample, comprising:

a) incubating a reaction mixture of claim 1 under amplification conditions, and

b) amplifying the template; wherein the amplification reaction is not helicase dependent but wherein the helicase reduces amplification of non-template molecules.

9. The method of claim 8 , wherein the amplification conditions are isothermal amplification conditions.

10. The method of claim 8 , wherein (b) results in whole genome amplification.

11. The method of claim 8 , wherein (b) results in amplification of one or more target fragments of a genome or cDNA.

12. The method of claim 8 , wherein the amplification conditions comprise thermocycling.

13. The method of claim 8 , wherein (b) results in reverse transcription of an RNA template.

14. The method of claim 13 , wherein (b) results in amplification of an RNA template by RT-PCR.

15. The method of claim 8 , wherein the method further comprises quantifying the amount of amplified template after (b).

16. The method of claim 8 , wherein the helicase is a PcrA/UvrD/Rep helicase.

17. The method of claim 8 , wherein the polymerase is selected from the group consisting of a Bst polymerase, a polD polymerase, 9° N polymerase and phi29 polymerase.

18. The method of claim 8 , wherein the reaction mixture is a loop-mediated isothermal amplification (LAMP) reaction mixture.

19. A loop-mediated isothermal amplification (LAMP) reaction mixture comprising:

a) a nucleic acid sample comprising a template;

b) nucleotides;

c) four or more primers;

d) a polymerase; and

e) a helicase;

wherein the reaction mixture optionally contains a single-stranded DNA binding protein (SSBP) and wherein the reaction mixture is capable of amplifying the template by LAMP.

20. The LAMP reaction mixture of claim 19 , wherein the mixture comprises six or more primers.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2014
From: TANNER, NATHAN; EVANS, THOMAS C., JR.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 033774/0631 →